Loading
Albert Koong is a radiation oncologist leading MD Anderson's radiation department, with a focus on pancreatic cancer and SBRT.
Albert Koong is Chair of the Department of Radiation Oncology at MD Anderson Cancer Center. A radiation oncologist and physician-scientist, his research covers stereotactic body radiotherapy for pancreatic ductal adenocarcinoma and the tumour hypoxia and unfolded-protein-response biology that shapes radiation response. His papers include a phase I study of stereotactic radiosurgery in locally advanced pancreatic cancer and a phase II study of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in the same setting. He now leads the radiation department at MD Anderson, working across SBRT and modern image-guided external beam techniques.
| Title | Journal | Year |
|---|---|---|
| Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer | International Journal of Radiation Oncology, Biology, Physics | 2004 |
| Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer | International Journal of Radiation Oncology, Biology, Physics | 2005 |
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy), Pancreatic ductal adenocarcinoma.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy).
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam), Pancreatic ductal adenocarcinoma.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam).
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy).
Shares Borderline resectable pancreatic ductal adenocarcinoma, Locally advanced unresectable pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam).
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam), Pancreatic ductal adenocarcinoma.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy).